Search Results - "Hunsche, E"

PCR172 Development of a Novel Patient-Reported Outcome (PRO) Measure to Assess Hormonal-Based Treatment Symptoms and Their Impacts in Patients with Prostate Cancer.

Authors: Chladek, M Hunsche, E Hudgens, S et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS573-S574. 2p.

The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment: A European Literature Review.

Authors: Hunsche, E. Chancellor, J.V.M. Bruce, N.

Source: PharmacoEconomics. Aug2001 Supplement 1, Vol. 19 Issue 8, p1-15. 15p. 2 Diagrams, 7 Charts, 3 Graphs.

Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland.

Authors: Chancellor, J.V.M. Hunsche, E. de Cruz, E. et al.

Source: PharmacoEconomics. Aug2001 Supplement 1, Vol. 19 Issue 8, p59-75. 17p. 1 Diagram, 9 Charts, 5 Graphs.

PCR291 Preferences for Key Features of Gonadotropin-Releasing Hormone Analogues Among Women With Endometriosis in the United States.

Authors: Beusterien, K Hunsche, E Kim, R et al.

Source: Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS447-S447. 1p.

POSB391 Patient-Perceived Burden of Pain in Uterine Fibroids: Results from a Prospective Real-World Evidence Study in the USA.

Authors: Hunsche, E Marshall, NJ Rakov, S et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS257-S257. 1p.

Pharmacological treatment of ankylosing spondylitis: a systematic review.

Authors: Boulos P Dougados M Macleod SM et al.

Source: Drugs. 2005, Vol. 65 Issue 15, p2111-2127.

URL: 18573373

PIH44 SURGICAL TREATMENT OF PATIENTS NEWLY DIAGNOSED WITH UTERINE FIBROIDS: A CLAIMS-BASED DATA ANALYSIS.

Authors: McKain, L. Hunsche, E. Edsall, K.

Source: Value in Health. 2019 Supplement 3, Vol. 22, pS635-S635. 1p.

PRS46 - Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden.

Authors: Wlodarczyk, J Hunsche, E Silberberg, B et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA556-A556. 1p.

Hospitalization Costs Related To Pulmonary Hypertension (Ph) Among Medicare Advantage Or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) In The United States.

Authors: Lacey, M. Hunsche, E. Buzinec, P. et al.

Source: Value in Health. May2013, Vol. 16 Issue 3, pA233-A233. 1p.

A literature review of the epidemiology and treatment of acute gout.

Authors: Kim KY Schumacher HR Hunsche E et al.

Source: Clinical Therapeutics. Jun2003, Vol. 25 Issue 6, p1593-1617. 25p.

PIH57 THE BLEEDING AND PELVIC DISCOMFORT SCALE: MEASURING PATIENT-REPORTED SYMPTOMS IN UTERINE FIBROIDS.

Authors: Li, J. Kang, J. Hunsche, E. et al.

Source: Value in Health. 2019 Supplement 3, Vol. 22, pS637-S638. 2p.

PSY17 - BUDGET IMPACT MODEL FOR SELEXIPAG: TAKING A US PAYER PERSPECTIVE.

Authors: Beaudet, A. Tsang, Y. Hunsche, E. et al.

Source: Value in Health. May2016, Vol. 19 Issue 3, pA243-A244. 1p.

PRM94 - Psychometric Validation Of The Fatigue Symptoms And Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rms™).

Authors: Hudgens, S. Schüler, R. Hunsche, E. et al.

Source: Value in Health. May2015, Vol. 18 Issue 3, pA26-A26. 1p.

Les patients présentant des ulcères digitaux actifs ont une sclérodermie plus sévère que les patients ayant un antécédent d’ulcères digitaux mais pas d’ulcère actif : résultats du registre « Digital Ulcers Observatory » (DUO)

Authors: Guillevin, L. Denton, C. Hunsche, E. et al.

Source: Revue de Médecine Interne. Dec2011 Supplement 2, Vol. 32, pS417-S417. 1p.

Sévérité de l’impact des ulcères digitaux sur les activités quotidiennes et professionnelles. Résultats du registre « Digital Ulcers Observatory » (DUO)

Authors: Guillevin, L. Denton, C. Hunsche, E. et al.

Source: Revue de Médecine Interne. Dec2011 Supplement 2, Vol. 32, pS416-S416. 1p.

Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK.

Authors: Jansen JP Pellissier J Choy EH et al.

Source: Current Medical Research & Opinion. Dec2007, Vol. 23 Issue 12, p3069-3078. 10p.

PCN151 Major Adverse Cardiovascular Event Hospitalization Burden in Patients with Prostate Cancer (PC) Receiving Androgen Deprivation Therapy (ADT) in the United States.

Authors: Brady, B. Pruett, J. Winer, I. et al.

Source: Value in Health. 2020 Supplement 2, Vol. 23, pS449-S450. 2p.

PRM154 - Psychometric Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire.

Authors: Gomberg-Maitland, M Channick, R Chin, K et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA385-A385. 1p.

PRM171 - Content Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire.

Authors: Gomberg-Maitland, M Channick, R Chin, K et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA388-A388. 1p.

Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in Belgium.

Authors: Chevalier, P. De Beule, J. Lamotte, M. et al.

Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA593-A593. 1p.